{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-029951","form_type":"8-K","ticker":"RVPH","cik":"0001742927","company_name":"REVIVA PHARMACEUTICALS HOLDINGS, INC.","filed_at":"2025-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.854609+00:00","generated_at":"2026-05-17T05:34:43.883449+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Reviva Pharmaceuticals reduces stockholder meeting quorum to 33⅓% of voting power","bullets":["Board adopted quorum reduction from majority to one-third (33⅓%) of outstanding voting stock.","Amendment effective September 26, 2025; applies to all stockholder meetings unless law or charter requires higher.","Previous Bylaws required a majority of shares entitled to vote in person or by proxy.","No other changes to the Bylaws were made."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-029951","json":"https://secwatch.observer/filing/0001437749-25-029951.json","markdown":"https://secwatch.observer/filing/0001437749-25-029951.md","text":"https://secwatch.observer/filing/0001437749-25-029951.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925029951/0001437749-25-029951-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925029951/rvph20250925_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:34:43.883449+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4b606be0cad877014184ece275c0820f1c45c89c","claim":"REVIVA PHARMACEUTICALS HOLDINGS, INC.: Reduced quorum requirement for stockholder meetings from majority of voting power to one-third of voting power (effective 2025-09-26).","evidence_excerpt":"The Amendment reduces the quorum at all meetings of the Company’s stockholders for the transaction of business, except as otherwise required by law or by the Company’s Amended and Restated Certificate of Incorporation, as amended, or Bylaws, to one-third (331⁄3%) of the voting power of the stock outstanding and entitled to vote at the meeting, present in person, present by remote communication, if applicable, or represented by proxy.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925029951/0001437749-25-029951-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2025-09-26"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}